✦ LIBER ✦

A case-control study of risk factors for hepatoblastoma. A report from the childrens cancer study group

✍ Scribed by Jonathan D. Buckley; Harland Sather; Kathy Ruccione; Paul C. J. Rogers; Joel E. Haas; Brian E. Henderson; G. Denman Hammond

Publisher: John Wiley and Sons
Year: 1989
Tongue: English
Weight: 817 KB
Volume: 64
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19890901)64:5<1169::aid-cncr2820640534>3.0.co;2-i

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Risk factors for prostate cancer: A nati

Risk factors for prostate cancer: A national case-control study

✍ Brian Cox; Mary J. Sneyd; Charlotte Paul; David C. G. Skegg 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 French ⚖ 74 KB 👁 2 views

## Abstract Statutory notification of cancer in New Zealand provided an opportunity to investigate risk factors for prostate cancer in a large national population‐based case‐control study. We analyzed data obtained from telephone interviews with 923 cases and 1,224 controls. For inclusion in the st

Tumors of the pineal and suprasellar reg

Tumors of the pineal and suprasellar region: Childrens cancer study group treatment results 1960–1975. A report from childrens cancer study group

✍ William M. Wara; Derek T. Jenkin; Audrey Evans; Inta Ertel; Robert Hittle; Jorge 📂 Article 📅 1979 🏛 John Wiley and Sons 🌐 English ⚖ 274 KB 👁 3 views

Risk factors for prostate cancer: a case

Risk factors for prostate cancer: a case-control study in Greece

✍ C.-c. Hsieh; A. Thanos; D. Mitropoulos; Ch. Deliveliotis; C.S. Mantzoros; D. Tri 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 French ⚖ 47 KB 👁 3 views

A case-control study of prostate cancer (PC) was undertaken in Athens, Greece. Cases were 320 patients with histologically confirmed incident disease, whereas controls were 246 patients without history or symptomatology of benign prostatic hyperplasia, treated in the same hospitals as the cases for

Phase I/II study of bisantrene in childh

Phase I/II study of bisantrene in childhood cancer: A report from the childrens cancer study group

✍ Movassaghi, Nasser ;Krivit, William A. ;Krailo, Mark D. ;Hammond, G. Denman 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 328 KB

A phase I/II study of bisantrene using a 3-week schedule was undertaken in 171 children with refractory leukemias and solid tumors. The doses ranged from 190 to 430 mg/m2. The maximum tolerated dose for children with solid tumors and acute leukemias was 280 mg/m2 and 360 mg/m2 every 3 weeks, respect

Risk factors for essential thrombocythem

Risk factors for essential thrombocythemia: A case-control study

✍ Alfonso Mele; Giuseppe Visani; Alessandro Pulsoni; Bruno Monarca; Guglielmo Cast 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 412 KB 👁 3 views

## BACKGROUND. Very little information is presently available regarding risk factors for essential thrombocythemia (ET). ## METHODS. A case-control study was performed to study the possible association between ET and selected behavioral, occupational, and environmental exposures. ## RESULTS.

Histiocytosis X: Clinical trial of chlor

Histiocytosis X: Clinical trial of chlorambucil: A report from childrens cancer study group

✍ Lahey, M. E. ;Heyn, R. M. ;Newton, W. A. ;Shore, N. ;Smith, W. B. ;Leikin, S. ;H 📂 Article 📅 1979 🏛 John Wiley and Sons 🌐 English ⚖ 366 KB

## Abstract A prospective study for histiocytosis X was designed to determine whether “good risk” patients, ie, those without evidence of dysfunction of liver, lung, or hemopoietic system, would respond to single agent therapy; in this case chlorambucil (CMB) used in a dose of 5 mgm/m^2^ /day. If t